[1]叶梦怡,马婷婷,马 颖,等.糖尿病性白内障治疗研究[J].医学信息,2020,33(09):53-56.[doi:10.3969/j.issn.1006-1959.2020.09.017]
　YE Meng-yi,MA Ting-ting,MA Ying,et al.Study on the Treatment of Diabetic Cataract[J].Medical Information,2020,33(09):53-56.[doi:10.3969/j.issn.1006-1959.2020.09.017]
点击复制

糖尿病性白内障治疗研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年09期
页码:
53-56
栏目:
综述
出版日期:
2020-05-01

文章信息/Info

Title:
Study on the Treatment of Diabetic Cataract
文章编号:
1006-1959（2020）09-0053-04
作者:
叶梦怡; 马婷婷; 马 颖; 等
（1.宁夏医科大学，宁夏 银川 750004；2.宁夏医科大学回医药现代化教育部重点实验室，宁夏 银川 750004；3.石嘴山市第一人民医院心内科，宁夏 石嘴山 753200）
Author(s):
YE Meng-yi; MA Ting-ting; MA Ying; et al
(1.Ningxia Medical University,Yinchuan 750004,Ningxia,China;2.Key Laboratory of Hui Medicine Modernization of Ministry of Education,Ningxia Medical University,Yinchuan 750004,Ningxia,China;3.Department of Cardiology,Shizuishan First People’s Hospital,Shizuishan 753200,Ningxia,China)
关键词:
糖尿病性白内障; 发病机制; 治疗方法
Keywords:
Diabetic cataract; Pathogenesis; Treatment
分类号:
R776.1
DOI:
10.3969/j.issn.1006-1959.2020.09.017
文献标志码:
A
摘要:
糖尿病性白内障是糖尿病并发症中仅次于视网膜病变的第2大眼病，其具有高发病率、高致盲率。目前临床治疗糖尿病性白内障主要包括手术治疗方式以及针对其中医病因病机和西医发病机制研发出的传统天然中药的内服外治、西药口服等非手术治疗方法，本文就糖尿病性白内障的发病机制以及治疗方法作一综述，以期改善患者视力，提高生活质量。
Abstract:
Diabetic cataract is the second largest eye disease after diabetic complications after diabetic complications.It has the characteristics of high incidence and high blindness. Study its pathogenesis and choose appropriate treatment methods for patients with diabetic cataract.Improving vision and improving quality of life are of great significance.At present,clinical treatment of diabetic cataract mainly includes surgical treatment.For the traditional natural Chinese medicine treatment of traditional Chinese medicine,etiology and pathogenesis,non-surgical treatment methods such as oral administration of western medicine,this article reviews the pathogenesis and treatment of diabetic cataract.

参考文献/References:

[1]代庆红,王忠东.中国糖尿病的现状调查[J].中国医药指南,2011,9(13):206-208.[2]费远丽,杨光,童毅.糖尿病相关眼病之中医病名初探[J].山西中医,2014,30(2):61-62.[3]Ivers RQ,Cumming RG,Mitchell P,et al.Diabetes and risk of fracture:The Blue Mountains Eye Study[J].Diabetes Care,2001,24(7):1198-1203.[4]Sayin N,Kara N,Pekel G.Ocular complications of diabetes mellitus[J].World Journal of Diabetes,2015,6(1):92-108.[5]唐丹梅,杜秋,孙士平.苄达赖氨酸治疗糖尿病性白内障的疗效观察[J].糖尿病新世界,2015(17):39-41.[6]王正芹.中西医结合治疗糖尿病性白内障疗效观察[J].中国民族民间医药,2010,19(16):157.[7]韩雪,苏胜,田霈,等.醛糖还原酶在糖尿病性白内障中的作用[J].现代生物医学进展,2015,15(7):1362-1364.[8]尹玉峰.糖尿病性白内障患者视网膜病变的治疗时机及临床疗效观察[J].中国医药指南,2019(16):61.[9]Zurawska-Plaksej E,Kratz EM,Ferens-Sieczkowska M,et al. Changes in glycosylation of human blood plasma chitotriosidase in patients with type 2 diabetes[J].Glycoconj J,2016,33(1):29-39. [10]党雅娥,王海燕.小切口白内障囊外摘除联合人工晶体植入术治疗白内障的效果[J].临床医学研究与实践,2018,3(34):98-100.[11]林莹,吴小桃,凌梓韵,等.超声乳化白内障摘除联合人工晶体植入术对房角结构的影响[J].广东医科大学学报,2019,37(3):291-293.[12]杨军岭,杨侠.糖尿病性白内障大鼠晶状体混浊程度的检测及肌肽阿司匹林治疗效果的评估[J].山西医药杂志,2011,40(3):245-247.[13]石海涛.谷胱甘肽滴眼液治疗白内障疗效观察[J].中国药物经济学,2013(4):113-114.[14]Sun J,Wang B,Hao Y,et al.Effects of calcium dobesilate on Nrf2,Keap1 and HO-1 in the lenses of D-galactose-induced cataracts in rats[J].Experimental and Therapeutic Medicine,2017,15(1):719-722.[15]Trevithick JR,Bantseev V,Hirst M,et al.Is pycnogenol a double-edged sword Cataractogenic in vitro,but reduces cataract risk in diabetic rats[J].Current Eye Research,2013,38(7):751-760.[16]赖洪康,黄海福,范志勇.温针灸治疗癌痛临床研究[J].中国中医急症,2011,20(10):1579,1586.[17]Follansbee MH,Beyer KH,Vesell ES.Studies on pyrazinoylguanidine.6.Prevention of cataracts in STZ-diabetic rats[J].Pharmacology,1997,54(5):256-260.[18]刘越峰,罗卫民.金樱子诱导HO-1表达对高糖条件下LECs活性氧产生及线粒体膜电位的影响[J].湖北医药学院学报,2013,32(5):412-415.[19]张剑,韩方菊.葛根素对糖尿病性白内障大鼠模型病情进展的影响[J].中国老年学杂志,2018,38(9):2195-2196.[20]楚艳玲.银杏叶提取物辅助性治疗糖尿病性白内障的治疗效果观察[J].郑州铁路职业技术学院学报,2013,25(4):44-45.[21]Sankeshi V,Anil Kumar P,Ravindar Naik R,et al.Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract[J].Journal of Ethnopharmacology,2013,149(1):215-221.[22]Fereshteh B,Seyedeh B,Seyed A,et al.Inhibitory Effect of Crocin(s)on Lens α-Crystallin Glycation and Aggregation, Results in the Decrease of the Risk of Diabetic Cataract[J].Molecules,2016,21(2):143.[23]张剑,齐艳秀,姜伟,等.白藜芦醇对糖尿病性白内障大鼠MDA、SOD和GSH-Px的影响[J].哈尔滨医科大学学报,2016,50(6):497-500.[24]易燕群,杨巧红,苏俊芳,等.抗糖性白内障候选Ⅰ类新药石斛滴眼液临床前质量控制、急毒及刺激性实验研究[J].中国中药杂志,2013,38(7):1061-1066.[25]董爽爽,李学鹏,王亭亭,等.姜黄素/微乳液的抗氧化性能[A]//中国化学会第30届学术年会摘要集-第十一分会：应用化学[C].2016.[26]辛薇,杨俐,崔硕,等.芪明颗粒联合依帕司他对糖尿病视网膜病变患者眼底血管造影、血液流变学及氧化应激的影响[J].现代中西医结合杂志,2019,28(24):2677-2680.[27]詹敏,李志英,王燕.内障丸加减方对氧化损伤大鼠晶状体上皮细胞中Bcl-2及Bax表达的影响[J].河北中医,2012,34(5):740-742,746,801.[28]刘青,肖家翔.石芍明目散对糖尿病鼠白内障抗氧化损伤的影响[J].中国中医眼科杂志,2009,19(2):67-70.[29]朱向东,王燕.五子衍宗丸对糖尿病性白内障小鼠晶状体氧化损伤和多元醇通路的影响[J].中医研究,2013,26(2):66-69.[30]李海霞,刘维彬,李智慧,等.吡诺克辛钠滴眼液的质量分析与标准改进[J].药学研究,2015,34(9):527-529.[31]吴群,郝丽丽,陶雯璇,等.聚维酮碘联合左氧氟沙星滴眼对糖尿病性白内障患者血清、泪液中炎性因子及抗氧化指标的影响[J].实用临床医药杂志,2017,21(24):123-124.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
　LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Medical Information,2018,31(09):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]王玉霞.剖宫产术后子宫疤痕妊娠的临床诊治[J].医学信息,2018,31(10):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
　WANG Yu-xia.Clinical Diagnosis and Treatment of Uterine Scar Pregnancy after Cesarean Section[J].Medical Information,2018,31(09):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
[3]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
　LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Medical Information,2022,35(09):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[4]只茂叶.重症急性胰腺炎的发病机制与内镜治疗研究[J].医学信息,2022,35(11):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
　ZHI Mao-ye.The Pathogenesis and Endoscopic Treatment of Severe Acute Pancreatitis[J].Medical Information,2022,35(09):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
[5]王煜婷.原发性痛经发病机制及口服药物治疗进展[J].医学信息,2018,31(13):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
　WANG Yu-ting.Research Progress in Pathogenesis and Oral Medication of Primary Dysmenorrhea[J].Medical Information,2018,31(09):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
　ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,31(09):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]马宏境,刘 彬.慢性阻塞性肺疾病发病机制的研究[J].医学信息,2019,32(10):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
　MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(09):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
[8]邵永康.维持性血液透析患者并发症的发病机制分析[J].医学信息,2019,32(17):35.[doi:10.3969/j.issn.1006-1959.2019.17.012]
　SHAO Yong-kang.Pathogenesis Analysis of Complications in Maintenance Hemodialysis Patients[J].Medical Information,2019,32(09):35.[doi:10.3969/j.issn.1006-1959.2019.17.012]
[9]齐尚忠,张 强.低位直肠癌前切除综合征的发病机制及防治研究[J].医学信息,2019,32(20):37.[doi:10.3969/j.issn.1006-1959.2019.20.011]
　QI Shang-zhong,ZHANG Qiang.Pathogenesis and Prevention of Low Rectal Cancer Anterior Resection Syndrome[J].Medical Information,2019,32(09):37.[doi:10.3969/j.issn.1006-1959.2019.20.011]
[10]苟青青,李 鸿.糖尿病相关眼部改变及并发症的研究[J].医学信息,2022,35(18):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]
　GOU Qing-qing,LI Hong.Study on Diabetes-related Ocular Changes and Complications[J].Medical Information,2022,35(09):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]

更新日期/Last Update: 2020-05-01